Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gamma-aminobutyric acid transporter 4 (GAT4) is a member of the neurotransmitter:sodium symporter family, responsible for the reuptake of gamma-aminobutyric acid (GABA), the primary inhibitory neurotransmitter in the central nervous system. It is primarily studied in rodents, and while there isn't a direct human ortholog named 'GAT4', BGT1/SLC6A12 may serve a similar function. GAT4 plays a crucial role in regulating extracellular GABA concentrations and thus modulates synaptic transmission and neuronal excitability. It differs from other GATs in its neuronal-specific localization and substrate specificity, including β-alanine. Disruption can lead to imbalances in neural inhibition, potentially contributing to neurological disorders.
Inhibition of GABA reuptake
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma-Aminobutyric Acid Transporter 4 (GAT4).